Metraipolis › archive › dc_d7cbf7ee89b5

EIF3M as a pan-cancer biomarker: prognostic significance and immune infiltration association — Europe PMC PMID:41341921

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41341921
DOI
10.3389/fmolb.2025.1697083
License (as archived)
solo-consultazione
Archived
2026-11-08T11:37:56.196Z
SHA-256 of the archived text
81bcbf0a984e9b4202cddc8116dcb46e44792d9b7a2609f35ec8ee80b9533a82
Stable URL of this page
https://metraipolis.com/documento/dc_d7cbf7ee89b5

How to cite

EIF3M as a pan-cancer biomarker: prognostic significance and immune infiltration association — Europe PMC PMID:41341921 — Europe PMC (en), https://europepmc.org/article/MED/41341921 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7cbf7ee89b5 (Metraipolis archive dc_d7cbf7ee89b5, sha256 81bcbf0a984e9b4202cddc8116dcb46e44792d9b7a2609f35ec8ee80b9533a82)
BibTeX
@misc{dcd7cbf7ee89b5,
  title = {EIF3M as a pan-cancer biomarker: prognostic significance and immune infiltration association — Europe PMC PMID:41341921},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41341921},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7cbf7ee89b5; sha256 81bcbf0a984e9b4202cddc8116dcb46e44792d9b7a2609f35ec8ee80b9533a82},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41341921. Agents can read the archived copy with the MCP tool read_document.